POPatricia Puccinelli Orlandi

Patricia Puccinelli Orlandi

*This is an algorithmically generated author record based on publicly available information.

Patricia Puccinelli Orlandi has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proteomic Analysis of Virulence Profiles in Clinical Strains of Shigella flexneri in Manaus – Amazon State

    by Fernanda Batalha, Isabelle B. Cordeiro, Paula Taquita, João Victor Verçosa, Alessandra Cavalcante, Ivanildes Santos, Daniel Figueiredo, Ruth Moura Souza, Paloma Dantas, Patrícia Orlandi

    Background: Shigella is a Gram-negative bacterium and belongs to Enterobacteriaceae family. These bacteria have been described as responsible for many diarrheic infections around the world and affects children as 5 years old. As a striking feature of these bacteria, we can say about the invasive capacity and the severe damage in the intestine of the host. Epidemiological studies conducted during 2007 to 2009 by our research group, Diagnosis and Control of Infectious Diseases of the Amazon - DCDIA, identified Shigella as the 4th most frequent bacterial pathogen in children with diarrhea treated in public hospitals in Manaus - AM. To understand the mechanisms of pathogenesis of these clinical strains, and to describe the mechanisms of cellular invasion, this study proposes the identification of the proteome of two isolates, through the mass spectrometry coupled to liquid chromatography. The clinical strains were submitted to experimental conditions that mimic the epithelial cellular contact in the host, using the inductor Congo Red, in order to investigate which proteins are being produced by this pathogen. Results: The proteomic profile of Shigella strain 201 reveals 386 intracellular proteins cultivated in LB medium and 189 intracellular proteins cultivated using the Congo Red inductor. For the M90T strain, a total of 470 intracellular proteins were detected in LB medium and 383 intracellular proteins cultivated with Congo Red. The findings reveal that proteins exclusively induced by Congo Red in the clinical strain are related to virulence processes, such as IpaC and IpaD proteins, which have already been extensively investigated in the literature. Conclusions: However, new target proteins are pointed out, such as Hmp, YkfE, AepA, MobC, MetK, OsmY, LptA and LuxS which are classified as proteins predicted as pathogenic, based on our analyses. Although such proteins are involved in the virulence of enteric pathogens, their functions are still little explored or inexistent for the Shigella genus, mainly in the northern region of Brazil. We expected this work to reveal the mechanisms underlying the isolated clinical strains and elucidate new effectors and how they modulate the pathogenesis of these bacteria.


  • Open Access

    Antibiotic resistance and biofilm formation in children with Enteropathogenic Escherichia coli (EPEC) in Brazilian Amazon

    by Renata Santos Rodrigues, Nucia Cristiane da Silva Lima, Roger Lafontaine Mesquita Taborda, Rosimar Pires Esquerdo, Antonieta Rodrigues Gama, Paulo Afonso Nogueira, Patricia Puccinelli Orlandi, Najla Benevides Matos

    Introduction: Enteropathogenic Escherichia coli is an important causative agent of diarrhea in both developed and developing countries. Methodology: We assessed the antibiotic resistance profile and the ability of 71 Enteropathogenic Escherichia coli (EPEC) isolates from children in the age group 6 years, or younger, to form biofilm. These children were hospitalized in Cosme and Damião Children Hospital in Porto Velho, Western Brazilian Amazon, between 2010 and 2012, with clinical symptoms of acute gastroenteritis. Results: The highest frequency of atypical EPEC (aEPEC) isolates reached 83.1% (59/71). Most EPEC isolates presented Localized Adherence Like (LAL) pattern in HEp-2 cells (57.7% - 41/71). Biofilm production was observed in 33.8% (24/71) of EPEC isolates, and it means statistically significant association with shf gene (p = 0.0254). The highest antimicrobial resistance rates and a large number of multiresistant isolates 67.6% (48/71), regarded cefuroxime (CXM), ampicillin (AMP), trimethoprim-sulfamethoxazole (SXT) and tetracycline (TET), respectively, mainly in typical EPEC (tEPEC). Furthermore, 96% (68/71) of EPEC isolates in the present study were resistant to at least one antibiotic, whereas only 3 isolates were sensitive to all the tested drugs. Conclusion: Based on our findings, there was increased aEPEC identification. EPEC isolates showed high resistance rate; most strains showed multiresistance; thus, they work as warning about the continuous need of surveillance towards antimicrobial use. Besides, the ability of forming biofilm was evidenced by the EPEC isolates. This outcome is worrisome, since it is a natural resistance mechanism of bacteria.


  • Open Access

    Zerumbone from Zingiber zerumbet (L.) smith: a potential prophylactic and therapeutic agent against the cariogenic bacterium Streptococcus mutans

    by Thiago Moreira da Silva, Carlos Danniel Pinheiro, Patricia Puccinelli Orlandi, Carlos Cleomir Pinheiro, Gemilson Soares Pontes

    Essential oil obtained from rhizomes of the Zingiber zerumbet (L.) Smith (popularly known in Brazil as bitter ginger) is mainly constituted by the biomolecule zerumbone, which exhibit untapped antimicrobial potential. The aim of this study was to investigate the antimicrobial activity of the zerumbone from bitter ginger rhizomes against the cariogenic agent Streptococcus mutans. Firstly, the essential oil from rhizomes of Zingiber zerumbet (L.) Smith extracted by hydrodistillation was submitted to purification and recrystallization process to obtain the zerumbone compound. The purity of zerumbone was determined through high-performance liquid chromatography analysis. Different concentrations of zerumbone were tested against the standard strain S. mutans (ATCC 35668) by using microdilution method. The speed of cidal activity was determined through a time kill-curve assay. The biological cytotoxicity activity of zerumbone was assessed using Vero cell line through MTT assay. The zerumbone showed a minimum inhibitory concentration (MIC) of 250 μg/mL and a minimum bactericidal concentration (MBC) of 500 μg/mL against S. mutans. After six hours of bacteria-zerumbone interaction, all concentrations tested starts to kill the bacteria and all bacteria were killed between 48 and 72 h period at the concentration of 500 μg/mL (99,99% of bacteria were killed in comparison with original inoculum). In addition, zerumbone showed no cytotoxicity activity on mammalian continuous cells line. These results draw attention to the potential of zerumbone as antimicrobial agent against S. mutans infection, indicating its possible use in the phyto-pharmaceutical formulations as new approach to prevent and treat tooth decay disease.


  • Open Access

    A hybrid protein containing MSP1a repeats and Omp7, Omp8 and Omp9 epitopes protect immunized BALB/c mice against anaplasmosis

    by Alex Sander R. Cangussu, Luis André M. Mariúba, Pritesh Lalwani, Keila Dayane E. S. Pereira, Spartaco Astolphi-Filho, Patricia P. Orlandi, Sabrina Epiphanio, Kelvison F. Viana, Mucio Flavio B. Ribeiro, Hidelberto M. Silva, et al.

    Anaplasma marginale (A. marginale) has a remarkable impact on livestock production, and an effective vaccine is not currently available due to the inexistence of a small animal model. Recently, BALB/c mice were successfully infected with A. marginale, resulting in an acute and persistent anaplasmosis infection. Here, we designed a hybrid protein containing repeats of polypeptide 1a from major surface protein-1 complex (MSP1a) repeats and common epitopes of outer membrane proteins (OMPs) OMP7, OMP8 and OMP9 expressed in Escherichia coli. Our proof-of-concept assessed vaccinal effectiveness against a challenge with live bacteria. The MSP1a/OMP7/8/9 immunized BALB/C mice exhibited a strong reduction in rickettsemia and had no signs of anaplasmosis or hepatic lesions. In contrast, the non-immunized mice exhibited signs of anaplasmosis and a body weight loss associated with increases in monocyte and neutrophil counts. Furthermore, the non-immunized mice displayed atrophies with chronic inflammatory infiltrates in the spleen and increased binucleation and hydropic degeneration in the hepatocytes. Our findings demonstrated that immunization with our hybrid protein induced a strong reduction in rickettsemia and conferred protection against anaplasmosis. Therefore, given the strong evidence of the protective effect against anaplasmosis, hybrid protein designs are potential candidates for the rational design of vaccinal subunits.